Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives

Noel Maclaren, Michael Lan, Regis Coutant, Desmond Schatz, Janet Silverstein, Andrew Muir, Michael Clare-Salzer, Jin-Xiong She, John Malone, Samual Crockett, Sherwyn Schwartz, Teresa Quattrin, Mark Desilva, Pierre Vander Vegt, Abner Notkins, Jeffrey Krischer

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

We report here our prospective study of 15,224 non-diabetic, first- degree relatives of probands with immune-mediated (type 1) diabetes (IMD), of which 135 were found to eventually develop diabetes. We determined islet cell, insulin, GAD65, insulinoma-associated antigen-2 and 2β autoantibodies (ICA, IAA, GAD65A, IA-2A and IA-2βA), on the first available serum samples. The latter three autoantibodies were however assayed on subsets of the relatives with and without ICA, IAA and/or GAD65A, plus most of the relatives who developed diabetes. Of the relatives who progressed to diabetes, 94% had at least one of these autoantibodies on the first screening, while ICA proved to be the most sensitive single marker (sensitivity 74%). Risk of diabetes was however negligible when ICA was found in the absence of the others (5- year risk=5.3%), but increased dramatically whenever two or more autoantibodies were present (5-year risk=28.2% and 66.2%, respectively). The most predictive combination of markers was ICA plus IA-2A and/or IA-2β A. Loss of first phase insulin release to IVGTT also occurred only in those ICA- positive relatives who had one or more of the other autoantibodies. The data suggests that significant β-cell damage is seen only when the underlying autoimmunity has spread to multiple antigenic islet cell determinants. Combinations of the autoantibodies occurred most often in relatives with the highest risk HLA-DR/DQ phenotypes. These data document that only relatives positive for at least two or more of these five autoantibodies are at significant risk of diabetes themselves. Intervention trials for the prevention of type 1 diabetes could be designed based on testing for these autoantibodies alone, without the need for HLA typing and IVGTT testing.

Original languageEnglish (US)
Pages (from-to)279-287
Number of pages9
JournalJournal of Autoimmunity
Volume12
Issue number4
DOIs
StatePublished - Jan 1 1999

Fingerprint

Type 1 Diabetes Mellitus
Islets of Langerhans
Autoantibodies
Insulin
HLA-DQ Antigens
Histocompatibility Testing
Insulinoma
HLA-DR Antigens
Autoimmunity
Prospective Studies
Phenotype
Antigens
Serum

Keywords

  • Autoantibodies
  • GAD65
  • HLA- DR/DQ
  • IA-2
  • IA-2β
  • Prediction
  • Relatives
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives. / Maclaren, Noel; Lan, Michael; Coutant, Regis; Schatz, Desmond; Silverstein, Janet; Muir, Andrew; Clare-Salzer, Michael; She, Jin-Xiong; Malone, John; Crockett, Samual; Schwartz, Sherwyn; Quattrin, Teresa; Desilva, Mark; Vander Vegt, Pierre; Notkins, Abner; Krischer, Jeffrey.

In: Journal of Autoimmunity, Vol. 12, No. 4, 01.01.1999, p. 279-287.

Research output: Contribution to journalArticle

Maclaren, N, Lan, M, Coutant, R, Schatz, D, Silverstein, J, Muir, A, Clare-Salzer, M, She, J-X, Malone, J, Crockett, S, Schwartz, S, Quattrin, T, Desilva, M, Vander Vegt, P, Notkins, A & Krischer, J 1999, 'Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives', Journal of Autoimmunity, vol. 12, no. 4, pp. 279-287. https://doi.org/10.1006/jaut.1999.0281
Maclaren, Noel ; Lan, Michael ; Coutant, Regis ; Schatz, Desmond ; Silverstein, Janet ; Muir, Andrew ; Clare-Salzer, Michael ; She, Jin-Xiong ; Malone, John ; Crockett, Samual ; Schwartz, Sherwyn ; Quattrin, Teresa ; Desilva, Mark ; Vander Vegt, Pierre ; Notkins, Abner ; Krischer, Jeffrey. / Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives. In: Journal of Autoimmunity. 1999 ; Vol. 12, No. 4. pp. 279-287.
@article{17b31248624540948097135ee1dc58e9,
title = "Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives",
abstract = "We report here our prospective study of 15,224 non-diabetic, first- degree relatives of probands with immune-mediated (type 1) diabetes (IMD), of which 135 were found to eventually develop diabetes. We determined islet cell, insulin, GAD65, insulinoma-associated antigen-2 and 2β autoantibodies (ICA, IAA, GAD65A, IA-2A and IA-2βA), on the first available serum samples. The latter three autoantibodies were however assayed on subsets of the relatives with and without ICA, IAA and/or GAD65A, plus most of the relatives who developed diabetes. Of the relatives who progressed to diabetes, 94{\%} had at least one of these autoantibodies on the first screening, while ICA proved to be the most sensitive single marker (sensitivity 74{\%}). Risk of diabetes was however negligible when ICA was found in the absence of the others (5- year risk=5.3{\%}), but increased dramatically whenever two or more autoantibodies were present (5-year risk=28.2{\%} and 66.2{\%}, respectively). The most predictive combination of markers was ICA plus IA-2A and/or IA-2β A. Loss of first phase insulin release to IVGTT also occurred only in those ICA- positive relatives who had one or more of the other autoantibodies. The data suggests that significant β-cell damage is seen only when the underlying autoimmunity has spread to multiple antigenic islet cell determinants. Combinations of the autoantibodies occurred most often in relatives with the highest risk HLA-DR/DQ phenotypes. These data document that only relatives positive for at least two or more of these five autoantibodies are at significant risk of diabetes themselves. Intervention trials for the prevention of type 1 diabetes could be designed based on testing for these autoantibodies alone, without the need for HLA typing and IVGTT testing.",
keywords = "Autoantibodies, GAD65, HLA- DR/DQ, IA-2, IA-2β, Prediction, Relatives, Type 1 diabetes",
author = "Noel Maclaren and Michael Lan and Regis Coutant and Desmond Schatz and Janet Silverstein and Andrew Muir and Michael Clare-Salzer and Jin-Xiong She and John Malone and Samual Crockett and Sherwyn Schwartz and Teresa Quattrin and Mark Desilva and {Vander Vegt}, Pierre and Abner Notkins and Jeffrey Krischer",
year = "1999",
month = "1",
day = "1",
doi = "10.1006/jaut.1999.0281",
language = "English (US)",
volume = "12",
pages = "279--287",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives

AU - Maclaren, Noel

AU - Lan, Michael

AU - Coutant, Regis

AU - Schatz, Desmond

AU - Silverstein, Janet

AU - Muir, Andrew

AU - Clare-Salzer, Michael

AU - She, Jin-Xiong

AU - Malone, John

AU - Crockett, Samual

AU - Schwartz, Sherwyn

AU - Quattrin, Teresa

AU - Desilva, Mark

AU - Vander Vegt, Pierre

AU - Notkins, Abner

AU - Krischer, Jeffrey

PY - 1999/1/1

Y1 - 1999/1/1

N2 - We report here our prospective study of 15,224 non-diabetic, first- degree relatives of probands with immune-mediated (type 1) diabetes (IMD), of which 135 were found to eventually develop diabetes. We determined islet cell, insulin, GAD65, insulinoma-associated antigen-2 and 2β autoantibodies (ICA, IAA, GAD65A, IA-2A and IA-2βA), on the first available serum samples. The latter three autoantibodies were however assayed on subsets of the relatives with and without ICA, IAA and/or GAD65A, plus most of the relatives who developed diabetes. Of the relatives who progressed to diabetes, 94% had at least one of these autoantibodies on the first screening, while ICA proved to be the most sensitive single marker (sensitivity 74%). Risk of diabetes was however negligible when ICA was found in the absence of the others (5- year risk=5.3%), but increased dramatically whenever two or more autoantibodies were present (5-year risk=28.2% and 66.2%, respectively). The most predictive combination of markers was ICA plus IA-2A and/or IA-2β A. Loss of first phase insulin release to IVGTT also occurred only in those ICA- positive relatives who had one or more of the other autoantibodies. The data suggests that significant β-cell damage is seen only when the underlying autoimmunity has spread to multiple antigenic islet cell determinants. Combinations of the autoantibodies occurred most often in relatives with the highest risk HLA-DR/DQ phenotypes. These data document that only relatives positive for at least two or more of these five autoantibodies are at significant risk of diabetes themselves. Intervention trials for the prevention of type 1 diabetes could be designed based on testing for these autoantibodies alone, without the need for HLA typing and IVGTT testing.

AB - We report here our prospective study of 15,224 non-diabetic, first- degree relatives of probands with immune-mediated (type 1) diabetes (IMD), of which 135 were found to eventually develop diabetes. We determined islet cell, insulin, GAD65, insulinoma-associated antigen-2 and 2β autoantibodies (ICA, IAA, GAD65A, IA-2A and IA-2βA), on the first available serum samples. The latter three autoantibodies were however assayed on subsets of the relatives with and without ICA, IAA and/or GAD65A, plus most of the relatives who developed diabetes. Of the relatives who progressed to diabetes, 94% had at least one of these autoantibodies on the first screening, while ICA proved to be the most sensitive single marker (sensitivity 74%). Risk of diabetes was however negligible when ICA was found in the absence of the others (5- year risk=5.3%), but increased dramatically whenever two or more autoantibodies were present (5-year risk=28.2% and 66.2%, respectively). The most predictive combination of markers was ICA plus IA-2A and/or IA-2β A. Loss of first phase insulin release to IVGTT also occurred only in those ICA- positive relatives who had one or more of the other autoantibodies. The data suggests that significant β-cell damage is seen only when the underlying autoimmunity has spread to multiple antigenic islet cell determinants. Combinations of the autoantibodies occurred most often in relatives with the highest risk HLA-DR/DQ phenotypes. These data document that only relatives positive for at least two or more of these five autoantibodies are at significant risk of diabetes themselves. Intervention trials for the prevention of type 1 diabetes could be designed based on testing for these autoantibodies alone, without the need for HLA typing and IVGTT testing.

KW - Autoantibodies

KW - GAD65

KW - HLA- DR/DQ

KW - IA-2

KW - IA-2β

KW - Prediction

KW - Relatives

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=0033020127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033020127&partnerID=8YFLogxK

U2 - 10.1006/jaut.1999.0281

DO - 10.1006/jaut.1999.0281

M3 - Article

C2 - 10330299

AN - SCOPUS:0033020127

VL - 12

SP - 279

EP - 287

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 4

ER -